जेरोधा के नितिन कामत का कहना है कि सस्ती वजन घटाने वाली दवाओं के लिए भारत की प्रतिक्रिया 'अजीब' है। यही कारण है कि

Generic GLP-1 weight-loss drugs have become significantly more affordable in India, but adoption remains slower than expected. Zerodha co-founder Nithin Kamath believes the issue isn't cost but long-term commitment, self-injections and cons